Bud BilanichSuccess Coach
Amy GilesIncreasing Engagement
Brenda SnowAuthentic Patient Voice
Matt TurnerPatient Affordability
Daniel SontupeMarket Access
Matthew DurhamOmnidynamic Marketing
Suma Ramadas, PhDMedical Affairs
Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
Paul TheisenPatient Acquisition
Pat PurcellMeeting Engagement
Liz KaneImpactful Strategy
David LinetskyPoint-of-Care Marketing
Joey CohenMedication Adherence
- OBE022 is ObsEva's potential first-in-class, oral and selective PGF2alpha receptor antagonist for the ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email